JUMP REPORT
Avg Daily Volume: 9,293,572 Market Cap: 1.49B
Sector: None Short Interest: 47.42
EARNINGS EXPECTATIONS:
THIS QTR: EPS: – .19/share REV: 219.52/M
___________________________________________________________
LAST QTR: EPS: -.09/share ACTUAL: -.25/share (MISS)
____________________________________________________________
NEXT QTR: EPS: -.18/share REV: 205.11/M
______________________________________________________
FULL YR: EPS: -.62/share REV: 911.94/M
______________________________________________________
*These are the base metrics we will be watching against the actual release numbers
__________________________________________________________________
BEAT/MISS RECORD: XX% OF THE TIME THEY BEAT ESTIMATES
PRIOR ‘JUMP ZONE’ MOVES (LAST 3 QTRS %) -30.53, -21.02
EXPECTED JUMP MOVE: 10-15%
——–
*** With market volatility at extremes during the coronavirus pandemic there is greater risk in trading these events which may not react as they would under normal market conditions. Please take extra caution before trading.
Links To Latest News and Headlines
For the quarter, SmileDirectClub posted total revenue of $152 million, which was a chunky (20%) improvement over the same period of 2021. This shook out to a mixed quarter for SmileDirectClub, as analysts tracking its stock were estimating it would book slightly over $134 million on the top line, but a slightly narrower per-share net loss of $0.16. “We are off to a good start for 2022 and on plan with the right-sizing of our operating structure and allocating capital to core growth initiatives that can produce the highest return on investment,” CEO David Katzman said of the quarter.
Before we begin, let me remind you that this conference call includes forward-looking statements. You should not rely on our forward-looking statements as predictions of future events. All forward-looking statements that we make on this call are based on assumptions and beliefs as of today.
SmileDirectClub’s (SDC) revenues declined year over year in the first quarter due to a drop in unique aligner shipments.
Now that the country looks more normal than ever since the start of the pandemic, people need to take care of their health holistically, which could benefit these dental stocks to buy. Henry Schein (HSIC): North America’s largest dental supply company, HSIC is the name to have as Americans head back to the dentist’s office. McKesson (MCK): A pharmaceutical distributor and manufacturer of various medical supplies, McKesson offers a range of oral care products. Becton Dickinson and Co. (BDX): Offe
SmileDirectClub (SDC) delivered earnings and revenue surprises of -11.76% and 10.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
StockJumpers analysis and trade plans are uploaded generally 1 HOUR BEFORE MARKETS CLOSE (3PM EST) for most events.
“I’m sorry, this content is for members only. To access this content, you must log in with your membership credentials – OR if you are not a member yet, visit our registration page here and get signed up Looking forward to having you on-board ASAP”
There is a significant amount of data behind the scenes involved in the analysis and trade plan tab above, that does not get put into the report. Too much information for traders often confuses things – so this is stripped down to only what is needed to make the best possible decision(s) on trading the trajectory.
NOTICE: All data on this site has been published for informational and educational purposes only and does not constitute an offer to sell nor a solicitation of an offer to buy any security which may be referenced here or in our websites. StockJumpers is not an Investment Adviser and relies on the publisher’s exemption as defined in Section 401(f) of the Uniform Securities Act, and provides no personal advice or recommendations. The services and published information contained herein is for non-commercial, educational use and display. StockJumpers and any of its affiliates does not represent that the securities or services discussed are suitable for any investor. You should assume that StockJumpers and or its management has or will take a position in the stock, whether it is stated or not. You are further advised not to rely on any information contained in this report and associated websites in the process of making a fully informed investment decision. Trading is risky and you can lose your investment. For the complete risk disclosure and other legal information please review the full Terms of Use Agreement.